Magellan Health (MGLN) Tops Q3 EPS by 8c, Revenues Beat; Lowers FY18 EPS Guidance Below Consensus, Affirms FY18 Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Magellan Health Reports Third Quarter 2018 Financial Results
November 7, 2018 6:30 AM ESTLowers 2018 Earnings Guidance
SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Health, Inc. (NASDAQ: MGLN) today announced financial results for the third quarter ended September 30, 2018, as summarized below:
Three Months Ended Nine Months Ended September 30 September 30 (In millions, except per share amounts) 2018 2017 Chg 2018 2017 Chg Net revenue $ 1,853.5 $ 1,419.4 30.6 % $ 5,469.5 $ 4,144.2 32.0 % Net income $ 27.1 $ 32.5 -16.4 % $... More